AstraZeneca COVID-19 antibody drug offers 83% protection over six months
These new data add to the growing body of evidence supporting AZD7442's potential to make a significant difference in the prevention and treatment of COVID-19
Thu Nov 18 2021
Ubat antibodi AstraZeneca terbukti berjaya dalam rawatan COVID-19
Ubat AZD7442 itu berpotensi mengurangkan risiko jangkitan COVID-19 atau kematian sebanyak 50 peratus.
Tue Oct 12 2021
AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19
The drug reduces the risk of developing severe COVID-19 or death by 50 pct in patients who had been symptomatic for seven days or less.
Mon Oct 11 2021
COVID-19: AZ mohon kelulusan FDA untuk rawatan cegah virus
Ini merupakan rawatan perlindungan pertama selain daripada vaksin untuk digunakan bagi melawan COVID-19.
Tue Oct 05 2021
AstraZeneca says prospect of COVID-19 drug success underscores value of vaccine ops
Antibody drug AZD7442 was shown to prevent COVID-19 in a trial.
Fri Aug 20 2021
AstraZeneca says its antibody treatment failed in preventing COVID-19 in exposed patients
Participants in the trial were unvaccinated adults aged 18 and above with confirmed exposure to a person with COVID-19 within eight days.
Tue Jun 15 2021